GAO, C. MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1. In Neoplasma. ISSN 0028-2685. Bratislava : AEPress, 2014, 2014, vol. 61, no. 6, s. 680-689.